Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Respiratory Research

Figure 3

From: Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

Figure 3

Kaplan-Meier estimates for A) time to first COPD exacerbation requiring oral corticosteroids, antibiotics and/or hospitalization, and B) time to withdrawal from study, over 26 weeks of treatment following the 3-week stabilization period, ITT population.COPD = chronic obstructive pulmonary disease; FP = fluticasone propionate; ITT = intent-to-treat; SAL = salmeterol.

Back to article page